Literature DB >> 19821719

Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.

Shigefumi Okamoto1, Atsuko Hata, Kay Sadaoka, Koichi Yamanishi, Yasuko Mori.   

Abstract

Cell-mediated immunity (CMI) has been shown to be critical for the prevention and control of varicella-zoster virus (VZV)-related diseases. Because a large population-based study has revealed that diabetes mellitus is a risk factor for herpes zoster, we studied VZV-specific immune responses of patients with diabetes mellitus and compared them with those of healthy individuals. In this study, we found that patients with diabetes mellitus had significantly lower CMI to VZV than did healthy individuals. These results suggest that the increased risk for herpes zoster among patients with diabetes mellitus may be related to decreased VZV-specific CMI.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19821719     DOI： 10.1086/644646

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  30 in total

1.  Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study.

Authors:  Michiel B Haeseker; Evelien Pijpers; Nicole Htm Dukers-Muijrers; Patty Nelemans; Christian Jpa Hoebe; Cathrien A Bruggeman; Annelies Verbon; Valère J Goossens
Journal:  Immun Ageing       Date:  2013-07-23       Impact factor: 6.400

2.  Chronic active varicella zoster virus infection.

Authors:  James Wolf; Maria A Nagel; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; Don Gilden
Journal:  Neurology       Date:  2012-08-08       Impact factor: 9.910

3.  Disseminated Cutaneous Herpes Zoster in a Patient with Uncontrolled Diabetes Mellitus.

Authors:  Shashikant Malkud; Santosh M Patil
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 4.  Reducing the burden of Herpes Zoster in Italy.

Authors:  Giovanni Gabutti; Elisabetta Franco; Paolo Bonanni; Michele Conversano; Antonio Ferro; Marzia Lazzari; Stefania Maggi; Alessandro Rossi; Silvestro Scotti; Francesco Vitale; Antonio Volpi; Donato Greco
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

6.  VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash.

Authors:  Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden
Journal:  J Neurol Sci       Date:  2013-01-11       Impact factor: 3.181

7.  Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.

Authors:  A Hata; M Kuniyoshi; Y Ohkusa
Journal:  Infection       Date:  2011-07-29       Impact factor: 3.553

8.  Breast implant extrusion related to Herpesviridae.

Authors:  Darmiga Thayabaran; Abrar Saiyed; Anita Maria Huws; Saira Khawaja; Simon Holt
Journal:  Int J Surg Case Rep       Date:  2015-08-17

9.  Disseminated cutaneous herpes zoster and multiple cerebral infarcts in an adult with diabetes mellitus.

Authors:  Chun-Fu Lin; Chien-Tai Hong; Wei-Hwa Lee; Dean Wu; Chaur-Jong Hu; Chen-Chih Chung
Journal:  J Neurovirol       Date:  2020-01-15       Impact factor: 3.739

10.  Herpes zoster and diabetes mellitus.

Authors:  Ivan Chernev; Eric Gomez
Journal:  Korean J Pain       Date:  2013-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.